克隆性血液形成在心力衰竭中的细胞内在影响
Wesley T Abplanalp1,2,3, Bianca Schuhmacher1,3, Sebastian Cremer1,2,3
1Institute of Cardiovascular Regeneration, Goethe University, Frankfurt, Germany.
Nature cardiovascular research
|August 28, 2024
概括
克隆性血液形成 (CHIP) 涉及血液干细胞的突变,恶化心力衰竭的结果. CHIP突变免疫细胞,如单细胞和T细胞,显示炎症和活化增加,放大疾病进展.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 产生于血液形成干细胞的体性突变.
- CHIP与心力衰竭患者的预后较差,并与炎症增加有关.
- 这种炎症的来源 - - 是来自突变细胞还是系统激活 - - 尚不清楚.
研究的目的:
- 研究CHIP突变细胞在心力衰竭患者中的细胞内在影响.
- 确定CHIP如何影响免疫细胞功能和炎症信号传递.
主要方法:
- 使用了一种先进的单细胞测序管道,MutDetect-Seq.
- 分析了单细胞,CD4+ T细胞和CHIP心力衰竭患者NK细胞的基因表达特征.
主要成果:
- DNMT3A突变单细胞,CD4+ T细胞和NK细胞显示出不同的改变基因表达特征.
- 突变单细胞显示炎症增加和与 fagocytosis 相关的基因.
- 突变的T细胞和NK细胞表现出高度的激活和效应器功能.
- 鉴定了突变和野生型单细胞和T细胞之间的副信号通路,放大了炎症电路.
结论:
- 奇普突变免疫细胞具有内在的促炎和激活特征.
- 这些细胞变化和放大了炎症信号,导致CHIP心力衰竭患者的预后更差.
- 提供了对CHIP在心血管疾病发病过程中的作用的新理解.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545


